PS
ABCL icon

Principal Securities’s AbCellera Biologics ABCL Stock Holding History

Principal Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,256
Closed -$6.32K – 1354
2025
Q3 		$6.32K Hold
1,256
– – ﹤0.01% 2885
2025
Q2 		$4.31K Sell
1,256
-177
-12% -$441 ﹤0.01% 2907
2025
Q1 		$4.2K Hold
1,433
– – ﹤0.01% 2833
2024
Q4 		$4.2K Sell
1,433
-36
-2% -$100 ﹤0.01% 2830
2024
Q3 		$3.82K Buy
1,469
+319
+28% +$884 ﹤0.01% 2760
2024
Q2 		$3.4K Sell
1,150
-38
-3% -$144 ﹤0.01% 2766
2024
Q1 		$5.38K Buy
1,188
+836
+238% +$4.27K ﹤0.01% 2579
2023
Q4 		$2.01K Buy
+352
New +$1.63K ﹤0.01% 2810

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return